XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.21.2

Earnings (Loss) Per Common Share | 9 Months Ended
--- | ---
Sep. 30, 2021
Earnings Per Share [Abstract] |
Earnings (Loss) Per Common Share | Earnings (Loss) Per Common Share The following table sets forth the computation of basic and diluted earnings per share available for common stockholders for the three and nine months ended September 30, 2021 and 2020 (in thousands, except per share data):
| For the Three Months Ended September 30, |  | For the Nine Months Ended September 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Income (loss) from continuing operations | $ | (13,040) |  |  | $ | (37,035) |  |  | $ | (33,337) |  |  | $ | (317,535) |
Income (loss) from discontinued operations, net of tax | — |  |  | (1,135) |  |  | 1,383 |  |  | (2,908) |
Net income (loss) | (13,040) |  |  | (38,170) |  |  | (31,954) |  |  | (320,443) |
Less: |  |  |  |  |  |  |
Net loss attributable to non-controlling interests | — |  |  | (822) |  |  | — |  |  | (822) |
Net income (loss) available for common shareholders - basic and diluted | $ | (13,040) |  |  | $ | (37,348) |  |  | $ | (31,954) |  |  | $ | (319,621) |
Weighted-average common shares outstanding - basic and diluted | 85,800 |  |  | 85,172 |  |  | 85,306 |  |  | 82,615 |
Income (loss) per common share |  |  |  |  |  |  |
Basic and diluted |  |  |  |  |  |  |
Continuing operations | $ | (0.15) |  |  | $ | (0.43) |  |  | $ | (0.39) |  |  | $ | (3.84) |
Discontinued operations | — |  |  | (0.01) |  |  | 0.02 |  |  | (0.03) |
Basic and diluted income (loss) per share attributable to common shareholders of Evolent Health, Inc. | $ | (0.15) |  |  | $ | (0.44) |  |  | $ | (0.37) |  |  | $ | (3.87) |
Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above for the three and nine months ended September 30, 2021 and 2020 are presented below:
| For the Three Months Ended September 30, |  | For the Nine Months Ended September 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Restricted stock units ("RSUs"), performance-based RSUs and leveraged stock units ("LSUs") | 2,012 |  |  | 1,042 |  |  | 1,700 |  |  | 600 |
Stock options | 2,004 |  |  | 1,362 |  |  | 2,008 |  |  | 1,016 |
Convertible senior notes | 12,696 |  |  | 9,789 |  |  | 12,696 |  |  | 10,169 |
Total | 16,712 |  |  | 12,193 |  |  | 16,404 |  |  | 11,785 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration